Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994). "Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients". Lancet. 343 (8893): 311–22. doi:10.1016/s0140-6736(94)91161-4. PMID7905143.
LATE trial intestigatos. (1993). "Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction". Lancet. 342 (8874): 759–66. doi:10.1016/0140-6736(93)91538-W. PMID8103874. S2CID26840289.
Sabatine MS, Morrow DA, Montalescot G, Dellborg M, Leiva-Pons JL, Keltai M, Murphy SA, McCabe CH, Gibson CM, Cannon CP, Antman EM, Braunwald E (2005). "Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial". Circulation. 112 (25). Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators.: 3846–54. doi:10.1161/CIRCULATIONAHA.105.595397. PMID16291601.
Lourenco DM, Dosne AM, Kher A, Samama M (1989). "Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro". Thromb Haemost. 62 (3): 923–6. doi:10.1055/s-0038-1651029. PMID2556812.
Bode C, Schoenermark S, Schuler G, Zimmermann R, Schwarz F, Kuebler W (1988). "Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction". Am J Cardiol. 61 (13): 971–4. doi:10.1016/0002-9149(88)90108-7. PMID2452564.
Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ (2000). "Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis". JAMA. 283 (20): 2686–92. doi:10.1001/jama.283.20.2686. PMID10819952.
Rokos IC, Larson DM, Henry TD, et al. (2006). "Rationale for establishing regional ST-elevation myocardial infarction receiving center (SRC) networks". Am Heart J. 152 (4): 661–7. doi:10.1016/j.ahj.2006.06.001. PMID16996830.
Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS (2005). "Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock". JAMA. 294 (4): 448–54. doi:10.1001/jama.294.4.448. PMID16046651.
Kaul TK, Fields BL, Riggins SL, Dacumos GC, Wyatt DA, Jones CR (1995). "Coronary artery bypass grafting within 30 days of an acute myocardial infarction". Ann. Thorac. Surg. 59 (5): 1169–76. doi:10.1016/0003-4975(95)00125-5. PMID7733715.
Raja SG, Haider Z, Ahmad M, Zaman H (2004). "Saphenous vein grafts: to use or not to use?". Heart Lung Circ. 13 (4): 403–9. doi:10.1016/j.hlc.2004.04.004. PMID16352226.
Hlatky MA, Boothroyd DB, Melsop KA, et al. (2004). "Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease". Circulation. 110 (14): 1960–6. doi:10.1161/01.CIR.0000143379.26342.5C. PMID15451795.
Osmancik PP, Stros P, Herman D (2008). "In-hospital arrhythmias in patients with acute myocardial infarction - the relation to the reperfusion strategy and their prognostic impact". Acute Cardiac Care. 10 (1): 15–25. doi:10.1080/17482940701474478. PMID17924228. S2CID24957172.
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994). "Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients". Lancet. 343 (8893): 311–22. doi:10.1016/s0140-6736(94)91161-4. PMID7905143.
LATE trial intestigatos. (1993). "Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction". Lancet. 342 (8874): 759–66. doi:10.1016/0140-6736(93)91538-W. PMID8103874. S2CID26840289.
Sabatine MS, Morrow DA, Montalescot G, Dellborg M, Leiva-Pons JL, Keltai M, Murphy SA, McCabe CH, Gibson CM, Cannon CP, Antman EM, Braunwald E (2005). "Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial". Circulation. 112 (25). Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators.: 3846–54. doi:10.1161/CIRCULATIONAHA.105.595397. PMID16291601.
Lourenco DM, Dosne AM, Kher A, Samama M (1989). "Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro". Thromb Haemost. 62 (3): 923–6. doi:10.1055/s-0038-1651029. PMID2556812.
Bode C, Schoenermark S, Schuler G, Zimmermann R, Schwarz F, Kuebler W (1988). "Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction". Am J Cardiol. 61 (13): 971–4. doi:10.1016/0002-9149(88)90108-7. PMID2452564.
Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ (2000). "Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis". JAMA. 283 (20): 2686–92. doi:10.1001/jama.283.20.2686. PMID10819952.
Rokos IC, Larson DM, Henry TD, et al. (2006). "Rationale for establishing regional ST-elevation myocardial infarction receiving center (SRC) networks". Am Heart J. 152 (4): 661–7. doi:10.1016/j.ahj.2006.06.001. PMID16996830.
Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS (2005). "Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock". JAMA. 294 (4): 448–54. doi:10.1001/jama.294.4.448. PMID16046651.
Kaul TK, Fields BL, Riggins SL, Dacumos GC, Wyatt DA, Jones CR (1995). "Coronary artery bypass grafting within 30 days of an acute myocardial infarction". Ann. Thorac. Surg. 59 (5): 1169–76. doi:10.1016/0003-4975(95)00125-5. PMID7733715.
Raja SG, Haider Z, Ahmad M, Zaman H (2004). "Saphenous vein grafts: to use or not to use?". Heart Lung Circ. 13 (4): 403–9. doi:10.1016/j.hlc.2004.04.004. PMID16352226.
Hlatky MA, Boothroyd DB, Melsop KA, et al. (2004). "Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease". Circulation. 110 (14): 1960–6. doi:10.1161/01.CIR.0000143379.26342.5C. PMID15451795.
Osmancik PP, Stros P, Herman D (2008). "In-hospital arrhythmias in patients with acute myocardial infarction - the relation to the reperfusion strategy and their prognostic impact". Acute Cardiac Care. 10 (1): 15–25. doi:10.1080/17482940701474478. PMID17924228. S2CID24957172.
LATE trial intestigatos. (1993). "Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction". Lancet. 342 (8874): 759–66. doi:10.1016/0140-6736(93)91538-W. PMID8103874. S2CID26840289.
Osmancik PP, Stros P, Herman D (2008). "In-hospital arrhythmias in patients with acute myocardial infarction - the relation to the reperfusion strategy and their prognostic impact". Acute Cardiac Care. 10 (1): 15–25. doi:10.1080/17482940701474478. PMID17924228. S2CID24957172.